Efficacy and Safety of neoadjuvant stereotactic body radiotherapy plus adebrelimab and chemotherapy for triple-negative breast cancer: A pilot study https://www.medrxiv.org/content/10.1101/2023.08.14.23294091
Efficacy and Safety of neoadjuvant stereotactic body radiotherapy plus adebrelimab and chemotherapy for triple-negative breast cancer: A pilot study https://www.medrxiv.org/content/10.1101/2023.08.14.23294091